BRIEF published on 07/24/2024 at 10:05, 2 years ago Fiven ASA annonce le remboursement d'obligations Fiven ASA Nasdaq Stockholm Rachat D'obligations Obligations Liées Au Développement Durable Changement De Contrôle
BRIEF published on 07/24/2024 at 10:05, 2 years ago Fiven ASA Announces Redemption of Bonds Fiven ASA Nasdaq Stockholm Change Of Control Sustainability-Linked Bonds Bond Redemption
PRESS RELEASE published on 07/24/2024 at 10:00, 2 years ago Fiven ASA announces redemption of bonds Fiven ASA announces redemption of EUR 110,000,000 senior secured sustainability-linked floating rate bonds according to the Terms and Conditions, with a redemption date of 31 July 2024 Fiven ASA Terms And Conditions Change Of Control Redemption Sustainability-Linked Bonds
BRIEF published on 07/15/2024 at 16:05, 2 years ago Fiven ASA publie un rapport d'avancement sur les obligations liées au développement durable Rachat Fiven ASA Obligation Liée Au Développement Durable Rapport D'étape
BRIEF published on 07/15/2024 at 16:05, 2 years ago Fiven ASA Publishes Sustainability-Linked Bond Progress Report Fiven ASA Sustainability-linked Bond Redemption Progress Report
PRESS RELEASE published on 07/15/2024 at 16:00, 2 years ago New Sustainability-linked bond progress report Fiven ASA releases sustainability-linked bond progress report in compliance with bond terms and conditions. Redemption of EUR 110,000,000 senior secured bonds planned Fiven ASA Sustainability-linked Bond Redemption Progress Report Bond Terms And Conditions
BRIEF published on 06/21/2024 at 18:20, 2 years 1 month ago Fiven ASA Announces Plan to Redeem EUR 110m Bonds Acquisition Fiven ASA Redemption EUR 110m Bonds
BRIEF published on 06/21/2024 at 18:20, 2 years 1 month ago Fiven ASA annonce un plan de rachat d'obligations de 110 millions d'euros Acquisition Rachat Fiven ASA Obligations De 110 Millions D'euros
PRESS RELEASE published on 06/21/2024 at 18:15, 2 years 1 month ago Intention to redeem outstanding EUR 110m bonds Fiven ASA intends to redeem its outstanding EUR 110m bonds following the acquisition by Kymera International, LLC, a portfolio company of Palladium Equity Partners, LLC Acquisition Fiven ASA Redemption Kymera International EUR 110m Bonds
BRIEF published on 06/05/2024 at 07:50, 2 years 2 months ago Binding Agreement for the Sale of Fiven Acquisition Silicon Carbide Fiven OpenGate Capital Kymera International
Published on 08/10/2026 at 11:00, 16 minutes ago Blue Lagoon Announces C$10 Million Strategic Investment by Nicola Mining and Ocean Partners
Published on 08/10/2026 at 08:00, 3 hours 16 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 3 hours 16 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 12 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/10/2026 at 10:12, 1 hour 3 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 1 hour 5 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 1 hour 26 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 2 hours 15 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:47, 1 hour 28 minutes ago 260810 BENETEAU Transactions sur actions propres
Published on 08/10/2026 at 09:22, 1 hour 53 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 53 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 4 hours 16 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 4 hours 16 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
